Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 5/31/16 → 5/30/18 |
Financiación
- United Biosource Corp: 21.138,00 US$
Randomized, Double-Blind, Phase 3 Study Evaluating TAS-102 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC In Patients With Metastatic Gastric Cancer Refractory to Standard Treatments
- Mathew, Aju (PI)
- Anthony, Lowell (CoI)
- Myers, Adria (CoI)
- Goel, Gaurav (Former PI)
- Hosein, Peter (Former CoI)